Compressed Colchicine Tablets vs Coated Colchicine Tablets for Familial Mediterranean Fever
Author Information
Author(s): Kaya Mehmet Nur, Canbaş Muhammed, Kılıç Özlem, Doğan Abdullah, Yılmaz Sedat, Diaconu Camelia Cristina
Primary Institution: Gülhane Training and Research Hospital, University of Health Sciences Turkey
Hypothesis
This study aimed to investigate the benefit of switching to compressed colchicine tablets in patients with FMF who are resistant or intolerant to coated colchicine tablets.
Conclusion
Compressed colchicine tablets were shown to be effective in patients who did not respond to coated colchicine therapy and those with pre-treatment intolerance to biological agents.
Supporting Evidence
- 75% of patients had 0-3 attacks after switching to compressed colchicine tablets.
- Diarrhea and aminotransferase elevation decreased significantly after using compressed colchicine tablets.
- The mean number of attacks per year decreased from 7.7 to 2.5 after switching treatments.
Takeaway
This study found that switching to a different type of colchicine tablet helped many patients with a disease called Familial Mediterranean Fever feel better and have fewer side effects.
Methodology
Patients resistant to coated colchicine were switched to compressed colchicine, and their attack frequencies and side effects were compared.
Limitations
This was a single-center and retrospective study, lacking direct comparisons of different colchicine preparations.
Participant Demographics
Mean age was 36.3 years, with 43.6% male; most patients were of North African, Jewish, Armenian, Turkish, and Arab origin.
Statistical Information
P-Value
<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website